ABSTRACT Bronchoalveolar lavage was performed in 97 patients including control patients with bronchial carcinoma (24) and patients with sarcoidosis (20), cryptogenic fibrosing alveolitis (9), and asthma (4), and others. Cytocentrifuged slides were stained by two methods: May-Grunwald Giemsa and toluidine blue. In the last 32 subjects the bronchoalveolar lavage fluid was separated into supernatant and cell pellet for the subsequent assay of the preformed mast cell mediator, histamine. Comparison of the two methods of staining showed a bias towards toluidine blue. Controls had a differential mean (SE) mast cell count of 0.07% (0.01%). Higher counts were noted in cryptogenic fibrosing alveolitis-0.61% (0.15%) (p < 0.001)-and in sarcoidosis-0.14% (0.02%) (p < 0.05). There was a strong correlation between absolute mast cell counts and cell lysate histamine concentration (r = 0.78, p < 0.001). Less strong, but significant, correlations between supernatant histamine concentration and absolute mast cell counts (r = 0.48, p < 0.01) or cell lysate histamine concentration (r = 0.72, p < 0.01) were also found. Derived mean values of histamine per mast cell ranged from 3.7 to 10.9 picograms. The mean histamine content of lavage fluid supernatant as a percentage of the total lavage fluid histamine was 24.9% (3.3%). The possible clinical significance of these findings is discussed.
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Human lungs are a particularly rich source of the vasoactive and bronchoactive amine histamine, which is almost entirely contained within the secretory granules of mast cells. Mast cells are located throughout the respiratory tract, both in the airways and in the alveoli. Within the distal airways they are mostly located beneath the respiratory epithelium superficial to the basement membrane,' although occasionally they are observed between epithelial cells and may abut directly on to the bronchial lumen.2 Mast cells are also found in association with alveolar capillaries and form a component of the alveolar walls, where they constitute 1.6-2.1% of the surface area.3 Not surprisingly therefore mast cells and basophil like cells have been identified in bronchoalveolar lavage fluid" and presumably originate from both the distal conducting airways and the alveoli.
Mast cell hyperplasia in the human gastrointestinal tract has been found in the chronic inflammation of Crohn's disease5 and gluten enteropathy6 and accompanying parasitic infections.7 In fibrotic lung diseases mast cell numbers have been shown to be increased in the pulmonary parenchyma and their appearances suggest partial degranulation, which might contribute to continuing alveolar injury.8 In support of this, bleomycin induced injury to the pulmonary parenchyma of rodents stimulates up to 10 fold increases in mast cell numbers and 14 fold increases in tissue histamine. 9 Mast cells may be activated by several mechanisms to secrete preformed and newly generated mediators, which have potent inflammatory properties. By analogy with animal models of antigen induced bronchoconstriction,'0 ' it is probably those mast cells adjacent to the airway lumen that are activated by inhaled provoking agents. These mast cells are likely to play a sentinel role in the ensuing inflammatory response, which is a characteristic pathological feature of airway diseases such as asthma'2 and chronic bronchitis. ' Systematic cytological investigation of bronchoalveolar lavage fluid has usually not included examination of mast cells.'3 Since there has been little investigation of mast cells and histamine reco-760
Mast cell and histamine content of human bronchoalveolar lavage fluid vered from lavage fluid in man,4 14 (24) , sarcoidosis (20) , and cryptogenic fibrosing alveolitis (9) . In addition, four patients with a clinical diagnosis of asthma were studied (the indication for bronchoscopy being haemoptysis in one and pulmonary shadowing-in three). Three of the asthmatic patients were receiving regular corticosteroid treatment (inhaled beclomethasone dipropionate in two and oral prednisolone in one). The remaining asthmatic patient was treated with regular /2 adrenoceptor agonists only. The diagnoses in the remaining patients are shown in table 1 . Subjects gave their informed consent for the procedure and the study was approved by the Southampton University and hospital ethical committee.
BRONCHOALVEOLAR LAVAGE
The lavage technique was adapted from that of Cole et al. '6 After premedication with intramuscular atropine and either intramuscular papaveretum or Agius, Godfrey, Holgate fields up to a total of about 10 000 nucleated cells and differential counts expressed as a percentage of the total. The intraobserver coefficient of variation was 17%.
ASSAYS
Histamine was assayed in bronchoalveolar lavage fluid supernatants and cell pellets by a microenzymatic single isotope radiotransfer assay using partially purified rat kidney histamine methyltransferase. The interassay and intra-assay coefficients of variation of this assay were 11% and 7% respectively, and the limit of histamine detection was 0.08 ng/ml.'8 Histamine contents were expressed in ng histamine per ml of lavage supernatant and per ml of cell lysate corrected to the original volume from which the pellet was derived. Albumin in the lavage fluid supernatants retained for histamine assay was assayed by a modified immunoturbidimetric method. '9 STATISTICS Since the groups of patients were not matched for age or sex, differences in mast cell counts were analysed by means of the Mann-Whitney U test. The two staining techniques used to identify mast cells were compared by calculating the difference between percentage counts for the two techniques for each lavage fluid sample. The mean of these differences is the relative bias and their standard deviation is the estimate of error. 20 The relationships between lavage fluid mast cell counts and cell associated and cell free histamine contents were established by unweighted and power least squares regression analyses. From the slope and intercept of these regression lines the theoretical mast cell content of histamine was calculated.
Results
No adverse reactions were observed during or after bronchoalveolar lavage in any of the patients studied. The mean (SE) volume of lavage fluid recovered from the instilled buffered saline was 39.6% (1.3%) and it contained 2.4 (0.5) x 107 nucleated cells.
The mast cells were identified on slides stained with May-Grunwald Giemsa by the metachromasia of their cytoplasmic granules. Metachromasia was more obvious with toluidine blue (fig 1) ated cells ranged from zero to 2.5%. More analysis showed that increased mast cell couI encountered in association with particular ( fig 2) . The mean (SE) differential mast ce from the contralateral lungs of those patie histologically proved bronchial carcinoma (c was 0.07% (0.01%). In the 20 patients u coidosis the mean mast cell count was (0.02%), which was significantly higher (p than that of the controls. In the nine subje cryptogenic fibrosing alveolitis a mean dif mast cell count of 0.61% (0.15%) was sign higher than that of either the control patiei 0.001) or those with sarcoidosis (p < 0.001 asthmatic patients who had been treated w ticosteroids had a mean differential mast cc of 0.085%, which was not different from control patients. The one asthmatic subject e not received corticosteroid treatment (but v had pulmonary eosinophilia) had an increased differential mast cell count of 0.5%. The highest differential mast cell count, 2.5%, was encountered in a patient with extrinsic allergic alveolitis related to exposure to avian proteins.
In the last 32 patients who underwent bronchoalveolar lavage the relationship between mast cell numbers and the histamine content of the cell pellet and supernatant was investigated. The group included six patients with carcinoma, six with sarcoidosis, five with cryptogenic fibrosing alveolitis, and four with asthma. For this heterogeneous group the number of mast cells recovered per ml of returned lavage fluid ranged from 10 to 6000. The histamine content of lysed cell pellets was always above the limit of detection of the assay. A significant positive correlation was observed between mast cell counts and cell associated histamine when analysis was by unweighted linear regression (r = 0.71, p < 0.001; y = 0.0037x -1.054). From the slope of the regression line the mean histamine content per mast cell was 3.7 pg. An improved correlation was observed when the data were analysed by a power regression (r = 0.78, p < 0.001) (fig 3) . Cell lysate histamnre (ng/ml) Mast cell and histamine content of human bronchoalveolar lavage fluid trols or patients with cryptogenic fibrosing alveolitis. In the patients with sarcoidosis, however, a significant correlation existed between mast cell and neutrophil counts (r = 0.48, p < 0.05), but not between mast cell and lymphocyte counts.
Discussion
This study confirms the presence of mast cells and the mast cell granule marker histamine in lavage fluid from subjects with a wide variety of pulmonary diseases. Furthermore, we have been able to establish a relationship between increased mast cell numbers and certain pulmonary diseases in which mast cells may play a pathogenetic role. Positive correlations found between mast cell numbers and cell associated and cell free histamine enabled calculation of the histamine content of lavage fluid mast cells and the "spontaneous" release of histamine.
Patterson et a'21 were the first to describe the presence of basophils and mast cells in bronchial lavage fluid, where a range of 0.36-0.7% was reported. In their study they described a high proportion of epithelial cells recovered from the lavage fluid (38% of nucleated cells), which probably reflected epithelial trauma to the airways during the lavage procedure and therefore could lead to erroneously high mast cell counts. The values for differential mast cell counts found in our controls (0.07%), in whom contralateral tumour free segments of lung were lavaged, were similar to those of Tomioka et al,4 who reported differential counts of 0.08% when mast cells were identified both by their metachromasia with toluidine blue and by the presence of cell surface IgE demonstrated by an immunofluorescent technique. The stains used in the present study were chosen because May-Grunwald Giemsa is a widely used general purpose stain used in cytological studies of bronchoalveolar lavage fluid and toluidine blue is a widely used stain to identify mast cells at mucosal surfaces or in connective tissue by granule metachromasia.7 9 17 22 In a study still in progress we are obtaining differential mast cell counts for lavage fluid similar to those reported here when using either Carnoy' s fixation followed by sequential staining with Alcian blue/Safranin 0 or acetone fixation followed by immunocytochemical staining for cell bound IgE. 23 The 4 The finding that the histamine content of bronchoalveolar lavage fluid cells correlated best with mast cell counts when a power regression was used to analyse the data (fig 3) suggests that, within individual patients and diseases, the mast cell content of histamine has a wide variation. Whether this reflects mast cell heterogeneity, in the sense of subpopulations of mast cells with different morphological, biochemical and pharmacological characteristics, awaits further study. The apparent morphological heterogeneity in terms of size and granule content of lavage mast cells is itself not good evidence for distinct subsets as it may represent varying cell maturity or degrees of activation. Morphological proof of heterogeneity would require the preparation and staining of cells by proved techniques closely matched for both lavage cells and control cell populations. Such important precautions must also hold true for functional comparisons with mast cells from other sources.
In the handling of mast cells from any source the possibility of loss of intracellular histamine through cell washing29 by lysis or activation is a matter for concern. Bronchoalveolar lavage handling does not require the mechanical or enzymatic dispersal of cells and so minimises the risk of loss of histamine from mast cells (which would result in an underestimate of mast cell histamine content and an overestimate of supernatant histamine). It remains possible, however, that a proportion of the lavage fluid supematant could contain some histamine of bacterial origin.30 When lavage cells are challenged with the calcium ionophore A23 187 or by reversed anaphylaxis with antihuman IgE most of the histamine that is physiologically accessible is released within the first two minutes of challenge,3' a time course that is more characteristic of mast cell than of basophil secretion.32 Release of histamine from bronchoalveolar lavage cells is closely paralleled by the generation of large amounts of prostaglandin D2,3' a prostanoid produced by mast cells but not by basophils. 32 The correlations between cell associated histamine and mast cell counts in our study were somewhat better than those reported by Tomioka et al. 4 On the basis of the tabular data presented in their paper for 26 subjects studied, an unweighted linear regression of histamine content against mast cell numbers per 106 nucleated cells give coefficients for a linear regression of 0.43 (p < 0.05) and for a power regression of 0.54 (p < 0.01). A better correAgius, Godfrey, Holgate lation found between these indices in our study is probably the result of the larger number of nucleated cells counted (10 000 v 3000) and because all our differential counts were carried out on dry permanent mounts. While we have also shown a significant correlation between the histamine content of bronchoalveolar lavage fluid supernatants and mast cell counts and cell associated histamine, the relationship between these measurements was not strong. Thus in our opinion it is difficult to draw useful conclusions regarding the contribution of mast cells to bronchoalveolar lavage fluid on the basis of cell free histamine measurements alone.
The ability to carry out bronchoalveolar lavage safely in selected patients should enable the further clarification of the role of mast cells in pulmonary diseases, although it is important to bear in mind the possible existence of heterogeneity among mast cells recovered by bronchoalveolar lavage, particularly with respect to their origin from the alveoli or airways.
